SEC 13F Intelligence

Jacobs & Co/Ca / AMGN

Jacobs & Co/Ca’s Amgen Inc Position

Does Jacobs & Co/Ca own Amgen Inc (AMGN)? Yes42.3K shares worth $15M (+1.31% of its 13F portfolio) as of Q2 2026, down from 43.1K shares the prior filed quarter.

Position Value
$15M
Q2 2026
Shares
42.3K
% of Portfolio
+1.31%
Quarters Held
30
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $8MQ4 ’18Q1 ’19: $7MQ2 ’19: $7MQ3 ’19: $8MQ4 ’19: $10MQ4 ’19Q1 ’20: $8MQ2 ’20: $9MQ4 ’20: $9MQ1 ’21: $10MQ1 ’21Q2 ’21: $10MQ3 ’21: $10MQ4 ’21: $11MQ1 ’22: $12MQ1 ’22Q2 ’22: $11MQ3 ’22: $11MQ4 ’22: $12MQ1 ’23: $11MQ1 ’23Q2 ’23: $10MQ3 ’23: $12MQ4 ’23: $13MQ1 ’24: $13MQ1 ’24Q2 ’24: $14MQ3 ’24: $14MQ4 ’24: $12MQ1 ’25: $14MQ1 ’25Q2 ’25: $12MQ3 ’25: $13MQ4 ’25: $14MQ1 ’26: $15MQ1 ’26Q2 ’26: $15Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202642.3K$15M+1.31%
Q1 202643.1K$15M+1.50%
Q4 202543.6K$14M+1.35%
Q3 202545.1K$13M+1.22%
Q2 202544.0K$12M+1.22%
Q1 202543.9K$14M+1.46%
Q4 202444.2K$12M+1.17%
Q3 202444.1K$14M+1.42%
Q2 202444.9K$14M+1.47%
Q1 202445.3K$13M+1.36%
Q4 202345.3K$13M+1.48%
Q3 202346.0K$12M+1.54%
Q2 202346.9K$10M+1.24%
Q1 202346.2K$11M+1.38%
Q4 202246.1K$12M+1.57%
Q3 202246.8K$11M+1.52%
Q2 202246.8K$11M+1.52%
Q1 202247.7K$12M+1.28%
Q4 202147.5K$11M+1.11%
Q3 202146.0K$10M+1.13%
Q2 202141.0K$10M+1.15%
Q1 202138.9K$10M+1.18%
Q4 202038.6K$9M+1.15%
Q2 202038.6K$9M+1.48%
Q1 202040.1K$8M+1.57%
Q4 201939.6K$10M+1.45%
Q3 201938.9K$8M+1.22%
Q2 201939.4K$7M+1.17%
Q1 201939.2K$7M+1.27%
Q4 201839.2K$8M+1.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Jacobs & Co/Ca’s full portfolio or all institutional holders of AMGN.